These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3378654)

  • 1. HLA and multiple skin carcinomas.
    Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
    Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between skin cancer and HLA antigens in renal-transplant recipients.
    Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
    N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and skin cancer.
    Bonamigo RR; Carvalho AV; Sebastiani VR; Silva CM; Pinto AC
    An Bras Dermatol; 2012; 87(1):9-16; quiz 17-8. PubMed ID: 22481646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin cancers and HLA frequencies in renal transplant recipients.
    Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
    Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and beta 2-microglobulin expression in basal and squamous cell carcinomas of the skin.
    Hua LA; Kagen CN; Carpenter RJ; Goltz RW
    Int J Dermatol; 1985 Dec; 24(10):660-3. PubMed ID: 3910595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA molecules in basal cell carcinoma of the skin.
    Cabrera T; Garrido V; Concha A; Martín J; Esquivias J; Oliva MR; Ruiz-Cabello F; Serrano S; Garrido F
    Immunobiology; 1992 Sep; 185(5):440-52. PubMed ID: 1452215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigens and multiple basal cell carcinomas.
    Rompel R; Petres J; Kaupert K; Müller-Eckhardt G
    Recent Results Cancer Res; 1995; 139():297-302. PubMed ID: 7597298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple basal cell carcinomas: no association with HLA-DRB, HLA-DQA1 or HLA-DQB1 in Swedish patients.
    Emtestam L; Wallberg P; Aldener A; Olerup O
    Br J Dermatol; 1996 May; 134(5):886-91. PubMed ID: 8736330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
    Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
    J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinoma.
    Kohchiyama A; Oka D; Ueki H
    J Am Acad Dermatol; 1987 Apr; 16(4):833-8. PubMed ID: 2952686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution of HLA-A, B, C, DR antigens in Chinese patients with hepatocellular carcinoma in Taiwan.
    Lin DY; Liaw YE; Huang CC
    Tissue Antigens; 1987 Feb; 29(2):110-4. PubMed ID: 3037726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
    Markey AC; Churchill LJ; MacDonald DM
    J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
    Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
    Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen associations in basal cell carcinoma.
    Myskowski PL; Pollack MS; Schorr E; Dupont B; Safai B
    J Am Acad Dermatol; 1985 Jun; 12(6):997-1000. PubMed ID: 3874217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
    Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
    Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple non-melanoma skin cancer: evidence that different MHC genes are associated with different cancers.
    Czarnecki D; Tait B; Nicholson I; Lewis A
    Dermatology; 1994; 188(2):88-90. PubMed ID: 8136554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple basal cell carcinomas and HLA frequencies in southern Australia.
    Czarnecki D; Lewis A; Nicholson I; Tait B
    J Am Acad Dermatol; 1991 Apr; 24(4):559-61. PubMed ID: 2033130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
    Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
    J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype frequencies in south-east Scotland.
    Jazwinska EC; Kilpatrick DC
    Tissue Antigens; 1987 Feb; 29(2):115-9. PubMed ID: 3474807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No HLA association with the early development of a single basal cell carcinoma.
    Czarnecki D; Nicholson I; Tait B; Meehan C
    Dermatology; 1995; 190(1):88. PubMed ID: 7894109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.